Indapamide is NOT an appropriate choice for diuresis in a patient with eGFR 32 mL/min/1.73 m²
Loop diuretics (furosemide, torsemide, or bumetanide) should be used instead of thiazide-type diuretics like indapamide when eGFR is <30 mL/min/1.73 m². 1
Why Indapamide is Inappropriate at This eGFR
The 2025 AHA/ACC hypertension guidelines explicitly state that loop diuretics are preferred over thiazide-type diuretics in patients with moderate-to-severe CKD (e.g., GFR <30 mL/min) 1. Your patient with eGFR 32 mL/min/1.73 m² sits at the threshold where thiazide-type diuretics lose effectiveness.
Key Pharmacologic Considerations:
- Indapamide requires adequate renal function for delivery to its site of action in the distal convoluted tubule 2, 3
- While indapamide can be used with caution in renal impairment 2, its diuretic efficacy diminishes substantially as GFR declines below 30 mL/min 4, 5
- The drug's antihypertensive effect may persist through vascular mechanisms even when diuretic effect is lost 6, 3, but this does not address the need for diuresis
What to Use Instead
Torsemide is the preferred loop diuretic for hypertension management due to its longer duration of action 1. Alternative loop diuretics include:
Important Caveats:
- Loop diuretics are mandatory in patients with symptomatic heart failure at any GFR 1
- At eGFR <30 mL/min, thiazide-type diuretics should be replaced or supplemented by loop diuretics 4
- Close monitoring of electrolytes (particularly potassium, sodium, and magnesium) is essential with any diuretic in advanced CKD 2
- Dose titration under clinical monitoring is crucial to find the lowest effective dose and minimize adverse effects 5
Clinical Pitfall to Avoid
Do not assume that because indapamide has some blood pressure-lowering effect through vascular mechanisms 6, 3, it will provide adequate diuresis in advanced CKD. The primary indication here is diuresis, and thiazide-type diuretics are ineffective for this purpose when GFR approaches 30 mL/min 1, 4, 5.